These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28117878)

  • 1. Siramesine causes preferential apoptosis of mast cells in skin biopsies from psoriatic lesions.
    Hagforsen E; Lampinen M; Paivandy A; Weström S; Velin H; Öberg S; Pejler G; Rollman O
    Br J Dermatol; 2017 Jul; 177(1):179-187. PubMed ID: 28117878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ablation of human skin mast cells in situ by lysosomotropic agents.
    Hagforsen E; Paivandy A; Lampinen M; Weström S; Calounova G; Melo FR; Rollman O; Pejler G
    Exp Dermatol; 2015 Jul; 24(7):516-21. PubMed ID: 25808581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes.
    Holstein J; Fehrenbacher B; Brück J; Müller-Hermelink E; Schäfer I; Carevic M; Schittek B; Schaller M; Ghoreschi K; Eberle FC
    J Dermatol Sci; 2017 Sep; 87(3):236-245. PubMed ID: 28673488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of tryptase-positive and bikunin-negative mast cells in psoriatic skin lesions.
    Ashenagar MS; Sugihara K; Maeda A; Isogai R; Takahashi M; Aisu K; Horiuchi A; Aragane Y; Kawada A; Tezuka T
    Arch Dermatol Res; 2007 Feb; 298(9):421-6. PubMed ID: 17146627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin.
    Jiang WY; Chattedee AD; Raychaudhuri SP; Raychaudhuri SK; Farber EM
    Int J Dermatol; 2001 Nov; 40(11):699-703. PubMed ID: 11737436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cell apoptosis induced by siramesine, a sigma-2 receptor agonist.
    Spirkoski J; Melo FR; Grujic M; Calounova G; Lundequist A; Wernersson S; Pejler G
    Biochem Pharmacol; 2012 Dec; 84(12):1671-80. PubMed ID: 23058984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcipotriol induces apoptosis in psoriatic keratinocytes.
    Tiberio R; Bozzo C; Pertusi G; Graziola F; Gattoni M; Griffanti P; Boggio P; Colombo E; Leigheb G
    Clin Exp Dermatol; 2009 Dec; 34(8):e972-4. PubMed ID: 19758385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed cell death of keratinocytes in infliximab-treated plaque-type psoriasis.
    Krüger-Krasagakis S; Galanopoulos VK; Giannikaki L; Stefanidou M; Tosca AD
    Br J Dermatol; 2006 Mar; 154(3):460-6. PubMed ID: 16445776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimentally induced psoriatic lesion associates with interleukin (IL)-6 in mast cells and appearance of dermal cells expressing IL-33 and IL-6 receptor.
    Suttle MM; Nilsson G; Snellman E; Harvima IT
    Clin Exp Immunol; 2012 Sep; 169(3):311-9. PubMed ID: 22861371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etanercept does not have an apoptosis-inducing effect on psoriatic keratinocytes.
    Tatlican S; Arikok A; Gulbahar O; Eren C; Cevirgen B; Eskioglu F
    J Dermatolog Treat; 2010 Sep; 21(5):306-10. PubMed ID: 19878038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion.
    Fischer M; Harvima IT; Carvalho RF; Möller C; Naukkarinen A; Enblad G; Nilsson G
    J Clin Invest; 2006 Oct; 116(10):2748-56. PubMed ID: 16964309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balance of Treg vs. T-helper cells in the transition from symptomless to lesional psoriatic skin.
    Keijsers RR; van der Velden HM; van Erp PE; de Boer-van Huizen RT; Joosten I; Koenen HJ; van de Kerkhof PC
    Br J Dermatol; 2013 Jun; 168(6):1294-302. PubMed ID: 23330679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin.
    Smit JV; de Jong EM; van Hooijdonk CA; Otero ME; Boezeman JB; van de Kerkhof PC
    J Am Acad Dermatol; 2004 Aug; 51(2):257-64. PubMed ID: 15280845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nature of cell kinetics in psoriatic epidermis.
    Doger FK; Dikicioglu E; Ergin F; Unal E; Sendur N; Uslu M
    J Cutan Pathol; 2007 Mar; 34(3):257-63. PubMed ID: 17302610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis.
    Mashiko S; Bouguermouh S; Rubio M; Baba N; Bissonnette R; Sarfati M
    J Allergy Clin Immunol; 2015 Aug; 136(2):351-9.e1. PubMed ID: 25792465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine.
    Onderdijk AJ; Baerveldt EM; Kurek D; Kant M; Florencia EF; Debets R; Prens EP
    J Immunol; 2015 Aug; 195(4):1744-52. PubMed ID: 26170379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin.
    Johansen C; Flindt E; Kragballe K; Henningsen J; Westergaard M; Kristiansen K; Iversen L
    J Invest Dermatol; 2005 Jun; 124(6):1284-92. PubMed ID: 15955105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of calcipotriol and methylprednisolone aseponate on bcl-2, p53 and ki-67 expression in psoriasis.
    Adişen E; Gülekon A; Erdem O; Dursun A; Gürer MA
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):527-33. PubMed ID: 16684279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cetirizine reduces the number of tryptase-positive mast cells in psoriatic patients: a double-blind controlled study.
    Pestelli E; Caproni M; Giomi B; Volpi W; Spallanzani A; Cardinali C; Floriani I; Fabbri P
    Int J Tissue React; 2001; 23(3):97-103. PubMed ID: 11517856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab restores the balance between pro- and anti-apoptotic proteins in regressing psoriatic lesions.
    Kokolakis G; Giannikaki E; Stathopoulos E; Avramidis G; Tosca AD; Krüger-Krasagakis S
    Br J Dermatol; 2012 Mar; 166(3):491-7. PubMed ID: 21985184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.